Overview
Berger Montague’s nationally recognized False Claims Act, Qui Tam, & Whistleblower Department has recovered More than $3 billion for federal and state governments, as well as over $500 million for our whistleblower clients.
Table of Contents
In 2025 alone, Berger Montague’s whistleblower department obtained over $1.9 billion in post-trial judgments. Our 2025 successes include the $1.64 billion final judgment entered in United States ex rel. Penelow v. Janssen Products, LP and the nearly $290 million final judgment in United States ex rel. Behnke v. CVS Caremark Corp. With very few FCA cases advancing to trial each year—and even fewer succeeding—these two victories stand out as extraordinary achievements by our whistleblower department. Both of these cases were declined by the Government. We litigated both cases on our own throughout, up to and including two trials.
Few firms are willing to take the risk of fully litigating a qui tam case where the government has declined to intervene. Even fewer firms are willing to do so against large corporations. But we do. And we have a record of winning.
Berger Montague’s award-winning team has litigated False Claims Act cases for over two decades. Berger lawyers Sherrie Savett, Joy Clairmont, Michael Fantini, and William Ellerbe won The Anti-Fraud Coalition’s Whistleblower Lawyers of the Year Award in 2024 for their work on United States ex rel. Silver v. Omnicare, Inc., PharMerica Corp, et al. and United States et al. ex rel. Penelow v. Janssen Products, LP. Both were government-declined cases that Berger Montague doggedly litigated for over a decade. In Janssen, on March 28, 2025, the Court decided all post-trial motions, whereby it trebled damages, imposed civil penalties, and entered Final Judgment against Janssen for over $1.6 billion. The PharMerica case, just 2 weeks before trial was to commence, settled for $100 million, plus statutory counsel fees.
Our Record of Success
The False Claims Act team cut its teeth over twenty years ago serving as counsel for the groundbreaking “AWP” whistleblower cases. These involved a series of actions filed in several federal and state courts against many of the largest drug companies for fraudulently overcharging the government for drugs. We worked tenaciously to secure settlements totaling over $2 billion for the federal and state governments.
Exceptional recoveries include:
- In United States ex rel Penelow v. Janssen Products, LP, No. 12-7758 (ZNQ)(JBD) (D.N.J.) Final Judgment against Janssen for over $1.6 billion. This represents one of the largest False Claims Act jury verdicts (in a government-declined case) in history.
- United States ex rel. Behnke v. CVS Caremark Corp. et al., No. 2:14-cv-00824 (E.D. Pa.) We obtained a $290 million final judgment.
- In United States ex rel Silver v. Omnicare, Inc. et al., No.11-cv-1326 (NLH) (AMD) (D.N.J.). After 13 years of hard-fought litigation, and just two weeks before trial, the parties settled this case for $100 million.
- United States ex rel. Zissa v. Santa Barbara County Alcohol, Drug, and Mental Health Services, et al. Case No: 14-cv-06891-DMG (RZX) (C.D.CAL.) Our team aggressively litigated this case, achieving a $28 million settlement for our client and the Federal government. It was one of the largest False Claims Act settlements against a public entity.
- United States ex rel. Streck v. Bristol-Myers Squibb Co., No. 2:13-cv-7547 (E.D. Pa.) We achieved a $75 million settlement on the eve of trial.
- United States ex rel. Kieff and LaCorte v. Wyeth and Pfizer, Inc., Nos. 03-12366 and 06-11724-DPW (D. Mass.) The case settled for $784.6 million.
- United States ex rel. Jain v. Universal Health Services, Inc., et al., No. 2:14-cv-00921 (E.D. Pa.) The government intervened in this case and related cases and reached a global settlement of $127 million.
- United States ex rel. Srivastava v. Trident USA Health Services LLC et al., No. 16-cv-2956 (E.D. Pa.) We obtained an $8.5 million settlement in this case within the context of a Chapter 11 bankruptcy proceeding.
- United States ex rel. Burris v. The Scripps Research Institute, No. 1:15-cv-01443 (D. Md.) This case, which dealt with NIH grant fraud, settled for $10 million.
Relationship with the Federal and State governments
We maintain a strong relationship with the US Attorneys in many states. We have been told over the years that the government offices look very carefully at the cases we present because of the thoroughness of our investigations and the quality of the complaints we file. The Firm has also successfully represented IRS and SEC whistleblowers.
No Fees Without Recovery
Berger Montague’s Whistleblower, Qui Tam & False Claims Act practice group litigates cases on a contingent fee basis, so whistleblowers do not pay attorneys’ fees or court costs unless there is a recovery.
Contact a Whistleblower Lawyer
Do you need a whistleblower lawyer, or do you want to know more about qui tam law?
To contact our firm:
- Use the Request a Free Confidential Consultation form.
- Email quitam@bergermontague.com.
- Contact any individual team member.
- Call (800) 424-6690
Your information will remain confidential while we evaluate your potential claims, and we will work with you to protect your rights.
Berger Montague is one of the nation’s preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law, employment law, securities, and whistleblower cases, among many other practice areas. For over 55 years, Berger Montague has played leading roles in precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, DC, and Wilmington, DE.